Skip to content
The Policy VaultThe Policy Vault

Mektovi (binimetinib tablets – Array BioPharma) — Cigna

Histiocytic Neoplasm

Initial criteria

  • Patient is age ≥ 18 years
  • Patient has Langerhans cell histiocytosis

Approval duration

1 year